Sign inGet started

Heyrman Reinilde

Insider CIK 1630929 · BLPH Chief Clinical Dev. Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BLPH Bellerophon Therapeutics, A Award deriv2015-03-122015-03-169,909— $09,909SEC↗
BLPH Bellerophon Therapeutics, P Buy2015-02-192015-02-231,500$12.00 $18.0K9,483SEC↗
BLPH Bellerophon Therapeutics, A Award deriv2015-02-132015-02-191,995— $01,995SEC↗